Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Heald

Showing results (41-50 of 185) with videos related to

Pageof 19
Sort By:
Cardiovascular Endocrinology & Metabolism|April 11, 2023
Enhancing type 2 diabetes treatment through digital plans of care. Patterns of access to a care-planning app over the first 3 months of a digital health interventionAdrian H Heald, Sarah Roberts, Lucia Albeda Gimeno, et al.
International Journal of Clinical Practice|March 15, 2018
The pattern of prescribing of glucose modulating agents for type 2 diabetes in general practices in England 2016/17Adrian H Heald, Mark Livingston, Zuzanna Bien, et al.
Cardiovascular Endocrinology & Metabolism|September 12, 2022
National level prescribing of psychotropic medication in primary care during the COVID-19 pandemic in England: potential implications for cardiometabolic healthUnaiza Waheed, Mike Stedman, Mark Davies, et al.
Clinical Endocrinology|March 1, 2003
Significant ethnic variation in total and free testosterone concentrationAdrian H Heald, Fiona Ivison, Simon G Anderson, et al.
Annals of Clinical Biochemistry|July 11, 2006
Most commercial insulin assays fail to detect recombinant insulin analoguesA H Heald, B Bhattacharya, H Cooper, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2004
Association between insulin-like growth factor-I: insulin-like growth factor-binding protein-1 ratio and metabolic and anthropometric factors in men and womenManjinder S Sandhu, J Martin Gibson, Adrian H Heald, et al.
International Journal of Clinical Practice|February 27, 2016
Serum testosterone, testosterone replacement therapy and all-cause mortality in men with type 2 diabetes: retrospective consideration of the impact of PDE5 inhibitors and statinsG Hackett, A H Heald, A Sinclair, et al.
Atherosclerosis|September 6, 2003
C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groupsAdrian H Heald, Simon G Anderson, Fiona Ivison, et al.
The Primary Care Companion for CNS Disorders|January 22, 2020
Quantifying the Impact of Patient-Practice Relationship Quality on the Levels of the Average Annual Antidepressant Practice Prescribing Rate in Primary Care in EnglandAdrian H Heald, Mike Stedman, Mark Davies, et al.
Human Psychopharmacology|June 5, 2020
Influences on the use of antidepressants in primary care: All England general practice-level analysis of demographic, practice-level and prescriber factorsAdrian H Heald, Mike Stedman, Mark Davies, et al.
Pageof 19

Showing results (41-50 of 185) with videos related to

Sort By:
Pageof 19
Cardiovascular Endocrinology & Metabolism|April 11, 2023
Enhancing type 2 diabetes treatment through digital plans of care. Patterns of access to a care-planning app over the first 3 months of a digital health interventionAdrian H Heald, Sarah Roberts, Lucia Albeda Gimeno, et al.
International Journal of Clinical Practice|March 15, 2018
The pattern of prescribing of glucose modulating agents for type 2 diabetes in general practices in England 2016/17Adrian H Heald, Mark Livingston, Zuzanna Bien, et al.
Cardiovascular Endocrinology & Metabolism|September 12, 2022
National level prescribing of psychotropic medication in primary care during the COVID-19 pandemic in England: potential implications for cardiometabolic healthUnaiza Waheed, Mike Stedman, Mark Davies, et al.
Clinical Endocrinology|March 1, 2003
Significant ethnic variation in total and free testosterone concentrationAdrian H Heald, Fiona Ivison, Simon G Anderson, et al.
Annals of Clinical Biochemistry|July 11, 2006
Most commercial insulin assays fail to detect recombinant insulin analoguesA H Heald, B Bhattacharya, H Cooper, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2004
Association between insulin-like growth factor-I: insulin-like growth factor-binding protein-1 ratio and metabolic and anthropometric factors in men and womenManjinder S Sandhu, J Martin Gibson, Adrian H Heald, et al.
International Journal of Clinical Practice|February 27, 2016
Serum testosterone, testosterone replacement therapy and all-cause mortality in men with type 2 diabetes: retrospective consideration of the impact of PDE5 inhibitors and statinsG Hackett, A H Heald, A Sinclair, et al.
Atherosclerosis|September 6, 2003
C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groupsAdrian H Heald, Simon G Anderson, Fiona Ivison, et al.
The Primary Care Companion for CNS Disorders|January 22, 2020
Quantifying the Impact of Patient-Practice Relationship Quality on the Levels of the Average Annual Antidepressant Practice Prescribing Rate in Primary Care in EnglandAdrian H Heald, Mike Stedman, Mark Davies, et al.
Human Psychopharmacology|June 5, 2020
Influences on the use of antidepressants in primary care: All England general practice-level analysis of demographic, practice-level and prescriber factorsAdrian H Heald, Mike Stedman, Mark Davies, et al.
Pageof 19